Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease

Chronic Respiratory Disease

Volumn 6, Issue 4, 2009, Pages 231-249

  Aboussouan, L S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Exercise; Fatigue; Muscle weakness; Neuromuscular diseases; Quality of life; Rehabilitation

Indexed keywords

ANTIINFLAMMATORY AGENT; CREATINE KINASE; DEFLAZACORT; DYSTROPHIN; IBUPROFEN; MYOGLOBIN; NEURONAL NITRIC OXIDE SYNTHASE; OXYGEN; SILDENAFIL; STEROID; TADALAFIL;

AEROBIC EXERCISE; AMYOTROPHIC LATERAL SCLEROSIS; APNEA; BECKER MUSCULAR DYSTROPHY; BREATHING; BREATHING EXERCISE; BREATHING MUSCLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DAYTIME SOMNOLENCE; DIAPHRAGM DISEASE; DIAPHRAGM MOVEMENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DUCHENNE MUSCULAR DYSTROPHY; DYNAMIC EXERCISE; DYSPNEA; ELECTROSTIMULATION; EXERCISE INTENSITY; EXERCISE TEST; EXERCISE TOLERANCE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERCAPNIA; HYPOVENTILATION; ISOMETRIC EXERCISE; KINESIOTHERAPY; LUNG GAS EXCHANGE; LUNG VENTILATION; METABOLIC DISORDER; MITOCHONDRIAL MYOPATHY; MOTOR NEURON DISEASE; MUSCLE ATONIA; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE INJURY; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCLE TRAINING; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOPATHY; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSICAL ACTIVITY; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; REM SLEEP; REVIEW; SENSORY NEUROPATHY; TOTAL LUNG CAPACITY; UNSPECIFIED SIDE EFFECT; URINALYSIS; VITAL CAPACITY; WALKING;

EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; LUNG DISEASES; NEUROMUSCULAR DISEASES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 70449366624     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972309345927     Document Type: Review

References (135)

1. Nici L., Donner C., Wouters E., et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006 ; 173: 1390-1413.
2. Carre PC, Didier AP, Tiberge YM, Arbus LJ, Leophonte PJ Amyotrophic lateral sclerosis presenting with sleep hypopnea syndrome. Chest 1988 ; 93: 1309-1312.
3. Guilleminault C., Stoohs R., Quera-Salva MA Sleep-related obstructive and nonobstructive apneas and neurologic disorders. Neurology 1992 ; 42: 53-60.
4. Cohen CA, Zagelbaum G., Gross D., Roussos C., Macklem PT Clinical manifestations of inspiratory muscle fatigue. Am J Med 1982 ; 73: 308-316.
5. Weisman IM, Zeballos RJ Clinical exercise testing. Clin Chest Med 2001 ; 22: 679-701.
6. Rochester DF, Esau SA Assessment of ventilatory function in patients with neuromuscular disease. Clin Chest Med 1994 ; 15: 751-763.
7. Griggs RC, Donohoe KM, Utell MJ, Goldblatt D., Moxley RT, III. Evaluation of pulmonary function in neuromuscular disease. Arch Neurol 1981 ; 38: 9-12.
8. Ries AL Measurement of lung volumes. Clin Chest Med 1989 ; 10: 177-186.
9. Sockolov R., Irwin B., Dressendorfer RH, Bernauer EM Exercise performance in 6-to-11-year-old boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1977 ; 58: 195-201.
10. Flaherty KR, Wald J., Weisman IM, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 2001 ; 164: 425-432.
11. Kilmer DD Response to aerobic exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002 ; 81: S148 - S150.
12. Rochester DF Respiratory muscles and ventilatory failure: 1993 perspective. Am J Med Sci 1993 ; 305: 394-402.
13. Tusiewicz K., Moldofsky H., Bryan AC, Bryan MH Mechanics of the rib cage and diaphragm during sleep. J Appl Physiol 1977 ; 43: 600-602.
14. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation -a consensus conference report. Chest 1999 ; 116: 521-534.
15. Ferguson KA, Strong MJ, Ahmad D., George CF Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest 1996 ; 110: 664-669.
16. Kimura K., Tachibana N., Kimura J., Shibasaki H. Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci 1999 ; 164: 37-43.
17. Santos C., Braghiroli A., Mazzini L., Pratesi R., Oliveira LV, Mora G. Sleep-related breathing disorders in amyotrophic lateral sclerosis. Monaldi Arch Chest Dis 2003 ; 59: 160-165.
18. Bradley TD, Phillipson EA Central sleep apnea. Clin Chest Med 1992 ; 13: 493-505.
19. Chen HI, Tang YR Sleep loss impairs inspiratory muscle endurance. Am Rev Respir Dis 1989 ; 140: 907-909.
20. Cooper KR, Phillips BA Effect of short-term sleep loss on breathing. J Appl Physiol 1982 ; 53: 855-858.
21. Zwarts MJ, Bleijenberg G., van Engelen BG Clinical neurophysiology of fatigue. Clin Neurophysiol 2008 ; 119: 2-10.
22. Schillings ML, Kalkman JS, Janssen HM, van Engelen BG, Bleijenberg G., Zwarts MJ Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol 2007 ; 118: 292-300.
23. Tam SL, Archibald V., Jassar B., Tyreman N., Gordon T. Increased neuromuscular activity reduces sprouting in partially denervated muscles. J Neurosci 2001 ; 21: 654-667.
24. Birk TJ Poliomyelitis and the post-polio syndrome: exercise capacities and adaptation-current research, future directions, and widespread applicability. Med Sci Sports Exerc 1993 ; 25: 466-472.
25. Yuen EC, Olney RK Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis. Neurology 1997 ; 49: 573-578.
26. Trojan DA, Gendron D., Cashman NR Stimulation frequency-dependent neuromuscular junction transmission defects in patients with prior poliomyelitis. J Neurol Sci 1993 ; 118: 150-157.
27. Tam SL, Archibald V., Tyreman N., Gordon T. Effect of exercise on stability of chronically enlarged motor units. Muscle Nerve 2002 ; 25: 359-369.
28. Tam SL, Gordon T. Neuromuscular activity impairs axonal sprouting in partially denervated muscles by inhibiting bridge formation of perisynaptic Schwann cells. J Neurobiol 2003 ; 57: 221-234.
29. Belanger AY, Noel G., Cote C. A comparison of contractile properties in the preferred and nonpreferred leg in a mixed sample of dystrophic patients. Am J Phys Med Rehabil 1991 ; 70: 201-205.
30. Granchelli JA, Pollina C., Hudecki MS Pre-clinical screening of drugs using the mdx mouse. Neuromuscul Disord 2000 ; 10: 235-239.
31. Lim JH, Kim DY, Bang MS Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle Nerve 2004 ; 30: 456-462.
32. Dunn JF, Tracey I., Radda GK Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice. Proc Biol Sci 1993 ; 251: 201-206.
33. Fowler WM, Jr. Importance of overwork weakness. Muscle Nerve 1984 ; 7: 496-499.
34. Brenman JE, Chao DS, Xia H., Aldape K., Bredt DS Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995 ; 82: 743-752.
35. Wehling M., Spencer MJ, Tidball JG A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001 ; 155: 123-132.
36. Sander M., Chavoshan B., Harris SA, et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2000 ; 97: 13818-13823.
37. Crosbie RH NO vascular control in Duchenne muscular dystrophy. Nat Med 2001 ; 7: 27-29.
38. Kobayashi YM, Rader EP, Crawford RW, et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008 ; 456: 511-515.
39. Ishizaki M., Suga T., Kimura E., et al. Mdx respiratory impairment following fibrosis of the diaphragm. Neuromuscul Disord 2008 ; 18: 342-348.
40. Thomas GD, Sander M., Lau KS, Huang PL, Stull JT, Victor RG Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 1998 ; 95: 15090-15095.
41. Kasai T., Abeyama K., Hashiguchi T., Fukunaga H., Osame M., Maruyama I. Decreased total nitric oxide production in patients with Duchenne muscular dystrophy. J Biomed Sci 2004 ; 11: 534-537.
42. Chao DS, Gorospe JR, Brenman JE, et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 1996 ; 184: 609-618.
43. Percival JM, Anderson KN, Gregorevic P., Chamberlain JS, Froehner SC Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One 2008 ; 3: e3387.
44. Acharyya S., Villalta SA, Bakkar N., et al. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007 ; 117: 889-901.
45. Pan Y., Chen C., Shen Y., et al. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol Cells 2008 ; 25: 531-537.
46. Petrof BJ The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 1998 ; 179: 111-123.
47. Griggs RC, Moxley RT, III, Mendell JR, et al. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol 1991 ; 48: 383-388.
48. Taivassalo T., Jensen TD, Kennaway N., DiMauro S., Vissing J., Haller RG The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain 2003 ; 126: 413-423.
49. Nardin RA, Johns DR Mitochondrial dysfunction and neuromuscular disease. Muscle Nerve 2001 ; 24: 170-191.
50. Echaniz-Laguna A., Zoll J., Ribera F., et al. Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol 2002 ; 52: 623-627.
51. Arnaudo E., Dalakas M., Shanske S., Moraes CT, DiMauro S., Schon EA Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991 ; 337: 508-510.
52. Dalakas MC, Illa I., Pezeshkpour GH, Laukaitis JP, Cohen B., Griffin JL Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990 ; 322: 1098-1105. (Pubitemid 20149526)
53. Santorelli FM, Sciacco M., Tanji K., et al. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 1996 ; 39: 789-795.
54. Beal MF Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998 ; 1366: 211-223.
55. Finsterer J. Lactate stress testing in sporadic amyotrophic lateral sclerosis. Int J Neurosci 2005 ; 115: 583-591.
56. Siciliano G., Pastorini E., Pasquali L., Manca ML, Iudice A., Murri L. Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci 2001 ; 191: 61-65.
57. Darras BT, Friedman NR Metabolic myopathies: a clinical approach; part I. Pediatr Neurol 2000 ; 22: 87-97.
58. Sanjak M., Paulson D., Sufit R., et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 1987 ; 37: 1217-1220.
59. Sharma KR, Kent-Braun JA, Majumdar S., et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 1995 ; 45: 733-740.
60. Sharma KR, Kent-Braun J., Mynhier MA, Weiner MW, Miller RG Excessive muscular fatigue in the postpoliomyelitis syndrome. Neurology 1994 ; 44: 642-646.
61. Schillings ML, Stegeman DF, Zwarts MJ Determining central activation failure and peripheral fatigue in the course of sustained maximal voluntary contractions: a model-based approach. J Appl Physiol 2005 ; 98: 2292-2297.
62. Kent-Braun JA, Miller RG Central fatigue during isometric exercise in amyotrophic lateral sclerosis. Muscle Nerve 2000 ; 23: 909-914.
63. Cup EH, Pieterse AJ, Knuijt S., et al. Referral of patients with neuromuscular disease to occupational therapy, physical therapy and speech therapy: usual practice versus multidisciplinary advice. Disabil Rehabil 2007 ; 29: 717-726.
64. Chen A., Montes J., Mitsumoto H. The role of exercise in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 2008 ; 19: 545-557.
65. Phillips BA, Mastaglia FL Exercise therapy in patients with myopathy. Curr Opin Neurol 2000 ; 13: 547-552.
66. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1994 ; 75: 560-563.
67. Wagner MB, Vignos PJ, Jr., Fonow DC Serial isokinetic evaluations used for a patient with scapuloperoneal muscular dystrophy. A case report. Phys Ther 1986 ; 66: 1110-1113.
68. Estenne M., Knoop C., Vanvaerenbergh J., Heilporn A., De Troyer A. The effect of pectoralis muscle training in tetraplegic subjects. Am Rev Respir Dis 1989 ; 139: 1218-1222.
69. Pinto AC, Alves M., Nogueira A., et al. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci 1999 ; 169: 69-75.
70. McCool FD, Tzelepis GE Inspiratory muscle training in the patient with neuromuscular disease. Phys Ther 1995 ; 75: 1006-1014.
71. Sanjak M., Reddan W., Brooks BR Role of muscular exercise in amyotrophic lateral sclerosis. Neurol Clin 1987 ; 5: 251-268.
72. Florence JM, Hagberg JM Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc 1984 ; 16: 460-465.
73. El Mhandi L., Millet GY, Calmels P., et al. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease. Muscle Nerve 2008 ; 37: 601-610.
74. Taivassalo T., De Stefano N., Chen J., Karpati G., Arnold DL, Argov Z. Short-term aerobic training response in chronic myopathies. Muscle Nerve 1999 ; 22: 1239-1243.
75. Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil 1996 ; 77: 64-69.
76. Siciliano G., Manca ML, Renna M., Prontera C., Mercuri A., Murri L. Effects of aerobic training on lactate and catecholaminergic exercise responses in mitochondrial myopathies. Neuromuscul Disord 2000 ; 10: 40-45.
77. Wiesinger GF, Quittan M., Graninger M., et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998 ; 37: 1338-1342.
78. Wiesinger GF, Quittan M., Aringer M., et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998 ; 37: 196-200.
79. Taivassalo T., De Stefano N., Argov Z., et al. Effects of aerobic training in patients with mitochondrial myopathies. Neurology 1998 ; 50: 1055-1060.
80. Sveen ML, Jeppesen TD, Hauerslev S., Kober L., Krag TO, Vissing J. Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 2008 ; 131: 2824-2831.
81. Dupont-Versteegden EE, McCarter RJ, Katz MS Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol 1994 ; 77: 1736-1741.
82. Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD Performance profiles of the functional independence measure. Am J Phys Med Rehabil 1993 ; 72: 84-89.
83. Liebetanz D., Hagemann K., von Lewinski F., Kahler E., Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 2004 ; 20: 3115-3120.
84. Dean E., Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics 1991 ; 14: 1243-1246.
85. Jones DR, Speier J., Canine K., Owen R., Stull GA Cardiorespiratory responses to aerobic training by patients with postpoliomyelitis sequelae. JAMA 1989 ; 261: 3255-3258.
86. De Troyer A., Estenne M., Heilporn A. Mechanism of active expiration in tetraplegic subjects. N Engl J Med 1986 ; 314: 740-744.
87. Estenne M., De Troyer A. Cough in tetraplegic subjects: an active process. Ann Intern Med 1990 ; 112: 22-28.
88. Fujiwara T., Hara Y., Chino N. Expiratory function in complete tetraplegics: study of spirometry, maximal expiratory pressure, and muscle activity of pectoralis major and latissimus dorsi muscles. Am J Phys Med Rehabil 1999 ; 78: 464-469.
89. van der Kooi EL, Lindeman E., Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2005: CD003907. DOI: 10.1002/14651858.CD003907.pub2.
90. Vignos PJ, Jr., Watkins MP The effect of exercise in muscular dystrophy. JAMA 1966 ; 197: 843-848.
91. Scott OM, Hyde SA, Goddard C., Jones R., Dubowitz V. Effect of exercise in Duchenne muscular dystrophy. Physiotherapy 1981 ; 67: 174-176.
92. de Lateur BJ, Giaconi RM Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 1979 ; 58: 26-36.
93. van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 2004 ; 63: 702-708.
94. Lindeman E., Leffers P., Spaans F., et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 1995 ; 76: 612-620.
95. Bello-Haas VD, Florence JM, Kloos AD, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007 ; 68: 2003-2007.
96. Drory VE, Goltsman E., Reznik JG, Mosek A., Korczyn AD The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001 ; 191: 133-137.
97. Skough K., Krossen C., Heiwe S., Theorell H., Borg K. Effects of resistance training in combination with coenzyme Q10 supplementation in patients with post-polio: a pilot study. J Rehabil Med 2008 ; 40: 773-775.
98. Lindeman E., Spaans F., Reulen J., Leffers P., Drukker J. Progressive resistance training in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol 1999 ; 9: 379-384.
99. Chetlin RD, Gutmann L., Tarnopolsky MA, Ullrich IH, Yeater RA Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2004 ; 30: 69-76.
100. Chetlin RD, Gutmann L., Tarnopolsky M., Ullrich IH, Yeater RA Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil 2004 ; 85: 1217-1223.
101. Winkler G., Zifko U., Nader A., et al. Dose-dependent effects of inspiratory muscle training in neuromuscular disorders. Muscle Nerve 2000 ; 23: 1257-1260.
102. Schiffman PL, Belsh JM Effect of inspiratory resistance and theophylline on respiratory muscle strength in patients with amyotrophic lateral sclerosis. Am Rev Respir Dis 1989 ; 139: 1418-1423.
103. Berto MC, Filha SC, Camelier A., Rosa FW, Souza Bulle OA, Jardim JR Acute action of aminophylline in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2007 ; 115: 301-305.
104. Wanke T., Toifl K., Merkle M., Formanek D., Lahrmann H., Zwick H. Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest 1994 ; 105: 475-482.
105. Koessler W., Wanke T., Winkler G., et al. 2 Yearsg' experience with inspiratory muscle training in patients with neuromuscular disorders. Chest 2001 ; 120: 765-769.
106. Martin AJ, Stern L., Yeates J., Lepp D., Little J. Respiratory muscle training in Duchenne muscular dystrophy. Dev Med Child Neurol 1986 ; 28: 314-318.
107. Ugalde V., Breslin EH, Walsh SA, Bonekat HW, Abresch RT, Carter GT Pursed lips breathing improves ventilation in myotonic muscular dystrophy. Arch Phys Med Rehabil 2000 ; 81: 472-478.
108. Fregonezi GA, Resqueti VR, Guell R., Pradas J., Casan P. Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest 2005 ; 128: 1524-1530.
109. Aboussouan LS, Khan SU, Meeker DP, Stelmach K., Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997 ; 127: 450-453.
110. Bourke SC, Tomlinson M., Williams TL, Bullock RE, Shaw PJ, Gibson GJ Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006 ; 5: 140-147.
111. Aboussouan LS, Khan SU, Banerjee M., Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001 ; 24: 403-409.
112. Borel JC, Wuyam B., Chouri-Pontarollo N., Deschaux C., Levy P., Pepin JL During exercise non-invasive ventilation in chronic restrictive respiratory failure. Respir Med 2008 ; 102: 711-719.
113. Tsuboi T., Ohi M., Chin K., et al. Ventilatory support during exercise in patients with pulmonary tuberculosis sequelae. Chest 1997 ; 112: 1000-1007.
114. Keilty SE, Ponte J., Fleming TA, Moxham J. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax 1994 ; 49: 990-994.
115. Maltais F., Reissmann H., Gottfried SB Pressure support reduces inspiratory effort and dyspnea during exercise in chronic airflow obstruction. Am J Respir Crit Care Med 1995 ; 151: 1027-1033.
116. vang't Hul A., Kwakkel G., Gosselink R. The acute effects of noninvasive ventilatory support during exercise on exercise endurance and dyspnea in patients with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil 2002 ; 22: 290-297.
117. Highcock MP, Smith IE, Shneerson JM The effect of noninvasive intermittent positive-pressure ventilation during exercise in severe scoliosis. Chest 2002 ; 121: 1555-1560.
118. Carvalho DC, de Cassia ZM, Sereni JM, Cliquet A. Metabolic and cardiorespiratory responses of tetraplegic subjects during treadmill walking using neuromuscular electrical stimulation and partial body weight support. Spinal Cord 2005 ; 43: 400-405.
119. Brown JA, Lutsep HL, Weinand M., Cramer SC Motor cortex stimulation for the enhancement of recovery from stroke: a prospective, multicenter safety study. Neurosurgery 2008 ; 62: 853-862.
120. DiMarco AF, Onders RP, Ignagni A., Kowalski KE Inspiratory muscle pacing in spinal cord injury: case report and clinical commentary. J Spinal Cord Med 2006 ; 29: 95-108.
121. DiMarco AF, Onders RP, Ignagni A., Kowalski KE, Mortimer JT Phrenic nerve pacing via intramuscular diaphragm electrodes in tetraplegic subjects. Chest 2005 ; 127: 671-678.
122. DiMarco AF, Onders RP, Kowalski KE, Miller ME, Ferek S., Mortimer JT Phrenic nerve pacing in a tetraplegic patient via intramuscular diaphragm electrodes. Am J Respir Crit Care Med 2002 ; 166: 1604-1606.
123. Smith CA, Chetlin RD, Gutmann L., Yeater RA, Alway SE Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2006 ; 34: 586-594.
124. Deschenes MR, Judelson DA, Kraemer WJ, et al. Effects of resistance training on neuromuscular junction morphology. Muscle Nerve 2000 ; 23: 1576-1581.
125. Brown J., Cooper-Kuhn CM, Kempermann G., et al. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 2003 ; 17: 2042-2046.
126. Kirkinezos IG, Hernandez D., Bradley WG, Moraes CT Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003 ; 53: 804-807.
127. Militello A., Vitello G., Lunetta C., et al. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J Neurol Sci 2002 ; 195: 67-70.
128. Pinto AC, Evangelista T., de Carvalho M., Paiva T., de Lurdes Sales-Luis M. Respiratory disorders in ALS: sleep and exercise studies. J Neurol Sci 1999 ; 169: 61-68.
129. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest 1997 ; 112: 1363-1396.
130. Bromberg MB Updating motor unit number estimation (MUNE). Clin Neurophysiol 2007 ; 118: 1-8.
131. Aboussouan LS, Lewis RA, Shy ME Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease. Lung 2007 ; 185: 1-7.
132. Tarnopolsky MA Clinical use of creatine in neuromuscular and neurometabolic disorders. Subcell Biochem 2007 ; 46: 183-204.
133. Jacobs SC, Bootsma AL, Willems PW, Bar PR, Wokke JH Prednisone can protect against exercise-induced muscle damage. J Neurol 1996 ; 243: 410-416.
134. Rahman MM, Hannan MA, Mondol BA, Bhoumick NB, Haque A. Prednisolone in Duchenne muscular dystrophy. Bangladesh Med Res Counc Bull 2001 ; 27: 38-42.
135. Aboussouan LS Respiratory disorders in neurologic diseases. Cleve Clin J Med 2005 ; 72: 511-520.